{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:32:14Z","timestamp":1761237134841},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1990,1]]},"DOI":"10.1007\/bf00053427","type":"journal-article","created":{"date-parts":[[2004,10,31]],"date-time":"2004-10-31T06:32:30Z","timestamp":1099204350000},"page":"53-58","source":"Crossref","is-referenced-by-count":21,"title":["Carcinoid syndrome and serotonin: Therapeutic effects of ketanserin"],"prefix":"10.1007","volume":"4","author":[{"given":"J. Ian S.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl 7","key":"CR1","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/00005344-198500077-00023","volume":"7","author":"H. Ahlman","year":"1985","unstructured":"Ahlman H. Serotonin and carcinoid tumors. J Cardiovasc Pharmacol 1985;7(Suppl 7):S79-S85.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR2","first-page":"459","volume":"67","author":"DG Grahame-Smith","year":"1988","unstructured":"Grahame-Smith DG. Serotonin (5-hydroxytryptamine, 5-HT). Q J Med 1988;67:459?466.","journal-title":"Q J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJM198712313172704","volume":"317","author":"CG Moertel","year":"1987","unstructured":"Moertel CG, Weiland LH, Nagorney DM, Dockerty MB. Carcinoid tumor of the appendix: Treatment and prognosis. N Engl J Med 1987;317:1699?1701.","journal-title":"N Engl J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/003693308002500313","volume":"25","author":"R Rankin","year":"1980","unstructured":"Rankin R, Nirodi NS, Browne MK. Carcinoid tumor of the oesophagus: Report of a case. Scott Med J, 1980;25:245?249.","journal-title":"Scott Med J"},{"key":"CR5","first-page":"103","volume":"31","author":"JIS Robertson","year":"1961","unstructured":"Robertson JIS, Peart WS, Andrews TM. The mechanism of facial flushes in the carcinoid syndrome. Q J Med 1961;31:103?123.","journal-title":"Q J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(61)92248-6","volume":"1","author":"JIS Robertson","year":"1961","unstructured":"Robertson JIS, Andrews TM. Free serotonin in human plasma: Quantitative and qualitative estimation. Lancet 1961;1:578?580.","journal-title":"Lancet"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(63)90952-8","volume":"1","author":"WS Peart","year":"1963","unstructured":"Peart WS, Porter KA, Robertson JIS, Sandler M, Baldock E. A carcinoid tumor due to pancreatic duct neoplasm secreting 5-hydroxytryptophan and 5-hydroxytryptamine. Lancet 1963;1:239?242.","journal-title":"Lancet"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(64)92907-1","volume":"1","author":"JA Oates","year":"1964","unstructured":"Oates JA, Melmon K, Sjoerdsma A, Gillespie L, Mason DT. Release of a kinin peptide in the carcinoid syndrome. Lancet 1964;1:514?517.","journal-title":"Lancet"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/bmj.288.6424.1111","volume":"288","author":"BK Sharma","year":"1984","unstructured":"Sharma BK, Smits BJ, Robinson R, Burns S, Tournson EN. Carcinold tumor secreting dopa. Br Med J 1984;288:111?112.","journal-title":"Br Med J"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/bmj.297.6658.1213","volume":"297","author":"HJF Hodgson","year":"1988","unstructured":"Hodgson HJF. Controlling the carcinoid syndrome. Br Med J 1988;297:1213?1214.","journal-title":"Br Med J"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/bmj.296.6623.682","volume":"296","author":"DG Menzies","year":"1988","unstructured":"Menzies DG, Campbell IW, Starkey IR. Infective endocarditis complicating tricuspid valve disease in the carcinoid syndrome. Br Med J 1988;296:682.","journal-title":"Br Med J"},{"key":"CR12","first-page":"367","volume":"56","author":"A Gupta","year":"1985","unstructured":"Gupta A, Saibil F, Kassim O, McKee J. Retroperitoneal fibrosis caused by carcinoid tumour. Q J Med 1985;56:367?375.","journal-title":"Q J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00001573-198809000-00007","volume":"3","author":"JIS Robertson","year":"1988","unstructured":"Robertson JIS. Serotonin, serotonin antagonists, hypertension and vascular diseases. Curr Opin Cardiol 1988; 3:702?714.","journal-title":"Curr Opin Cardiol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0140-6736(59)92137-3","volume":"2","author":"WS Peart","year":"1959","unstructured":"Peart WS, Robertson JIS, Andrews TM. Facial flushing produced in patients with carcinoid syndrome by intravenous adrenaline and noradrenaline. Lancet 1959; 2:715?716.","journal-title":"Lancet"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM197811092991908","volume":"299","author":"JC Frolich","year":"1978","unstructured":"Frolich JC, Bloomgarten ZT, Oates JA, McGuigan JE, Rabinowitz D. The carcinoid flush: Provocation by pentagastrin and inhibition by somatostatin. N Engl J Med 1978;299:1055?1057.","journal-title":"N Engl J Med"},{"issue":"Suppl 7","key":"CR16","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/00005344-198500077-00024","volume":"7","author":"H Ahlman","year":"1985","unstructured":"Ahlman H, Dahlstrom A, Gronstad K, Jaffe BM, Nilsson O, Oberg K. The pentagastrin test in the diagnosis of the carcinoid syndrome. J Cardiovasc Pharmacol 1985;7(Suppl 7):S86-S88.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/01.HYP.11.2.111","volume":"11","author":"P Vanhoutte","year":"1988","unstructured":"Vanhoutte P, Amery A, Birkenh\u00e4ger W, et al. Serotonergic mechanisms in hypertension: Focus on ketanserin. Hypertension 1988;11:111?133.","journal-title":"Hypertension"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/00365528609011123","volume":"21","author":"J Gustafsen","year":"1986","unstructured":"Gustafsen J, Lendorf A, Raskov H, Boesby S. Ketanserin versus placebo in carcinoid syndrome: A clinical controlled trial. Scand J Gastroenterol 1986;21:816?818.","journal-title":"Scand J Gastroenterol"},{"key":"CR19","unstructured":"Friis J, Stage JG, Fischerman NK, Winther K. Trial of ketanserin treatment in carcinoid syndrome: Reversal of platelet activation by ketanserin. Proceedings, International Workshop on Serotonin, Platelets and Disease, Stockholm, 1983:1?2."},{"key":"CR20","first-page":"81","volume":"201","author":"H Ahlman","year":"1985","unstructured":"Ahlman H, Dahlstrom A, Gronstadt K, Tisell LE, Oberg K, Zinner MJ, Jaffe BM. The pentagastrin test in the diagnosis of the carcinoid syndrome: Blockade of gastrointestinal symptoms by ketanserin. Ann Surg 1985; 201:81?86.","journal-title":"Ann Surg"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF02940548","volume":"155","author":"PA Sullivan","year":"1985","unstructured":"Sullivan PA, O'Donovan M. Ketanserin, a 5-HT antagonist, onistin symptomatic treatment of carcinoid syndrome. Irish J Med Sci 1985;155:436.","journal-title":"Irish J Med Sci"},{"key":"CR22","unstructured":"Janssen Pharmaceutica, Beerse, Belgium. Clinical and Research File on Ketanserin."},{"key":"CR23","unstructured":"Howse JJ. Ketanserin in a patient with carcinoid syndrome during open heart surgery. Janssen Clinical ReportN26 290."},{"key":"CR24","unstructured":"Zuurmond WWA, Van Der Kun JEM, Scheijgrond H. Treatment of circulatory complications during anaesthesia for the removal of a carcinoid tumour with ketanserin, a new selective competitive serotonin antagonist. Janssen Clinical Report N27505."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/bja\/55.9.920","volume":"55","author":"M Fischler","year":"1983","unstructured":"Fischler M, Dentan M, Westerman MN, Vourch G, Freitag B. Prophylactic use of ketanserin in a patient with carcinoid syndrome. Br J Anaesth 1983;55:920.","journal-title":"Br J Anaesth"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2044.1986.tb13050.x","volume":"41","author":"K Houghton","year":"1986","unstructured":"Houghton K, Carter JA. Peri-operative management of carcinoid syndrome using ketanserin. Anaesthesia 1986; 41:596?599.","journal-title":"Anaesthesia"},{"key":"CR27","first-page":"809","volume":"65","author":"PA Castheley","year":"1986","unstructured":"Castheley PA, Jablons M, Griepp RB, Ergin MA, Goodman K. Ketanserin in the pre-operative and intra-operative management of a patient with carcinoid tumor undergoing tricuspid valve replacement. Anesth Analg 1986;65:809?811.","journal-title":"Anesth Analg"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(81)92352-7","volume":"1","author":"JC Demoulin","year":"1981","unstructured":"Demoulin JC, Bertholet M, Soumagne D, David JL, Kulbertus HE. 5-HT2 receptor blockade in the treatment of heart failure. Lancet 1981;1:1186?1188.","journal-title":"Lancet"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.287.6397.932","volume":"287","author":"PN Maton","year":"1983","unstructured":"Maton PN, Camilleri M, Griffin G, Allison DJ, Hodgson HJF, Chadwick VS. Role of hepatic arterial embolisation in the carcinoid syndrome. Br Med J 1983;287:932?935.","journal-title":"Br Med J"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(61)90846-7","volume":"2","author":"WS Peart","year":"1961","unstructured":"Peart WS, Robertson JIS. The effect of a serotonin antagonist, methysergide (UML 491), in carcinoid disease. Lancet 1961;2:1172?1174.","journal-title":"Lancet"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/bmj.296.6623.682-a","volume":"296","author":"M Noppen","year":"1988","unstructured":"Noppen M, Jacobs A, Van Belle S, Herregodts P, Somers G. Inhibitory effects of ranitidine on flushing and serum serotonin concentrations in carcinoid syndrome. Br Med J 1988;296:682?683.","journal-title":"Br Med J"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198307213090301","volume":"309","author":"K Oberg","year":"1983","unstructured":"Oberg K, Funa K, Alm G. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome. N Engl J Med 1983;309:129?133.","journal-title":"N Engl J Med"},{"key":"CR33","first-page":"429","volume":"306","author":"SM Stahl","year":"1982","unstructured":"Stahl SM, Levin B, Freedman DX. Serotonin depletion by fenfluramine in the carcinoid syndrome. N Engl J Med 1982;306:429.","journal-title":"N Engl J Med"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","volume":"315","author":"LK Kvols","year":"1986","unstructured":"Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG. Treatment of the malignant carcinoid syndrome: Evaluation of a long-acting somatostatin analogue. N Engl J Med 1986;315:663?666.","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00053427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00053427\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00053427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T23:50:50Z","timestamp":1554249050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00053427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["BF00053427"],"URL":"https:\/\/doi.org\/10.1007\/bf00053427","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,1]]}}}